The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging
Open accessThe DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.
Abstract
In this study, a comparative analysis of metal-related neuronal vulnerability was performed in two brainstem nuclei, the locus coeruleus (LC) and substantia nigra (SN), known targets of the etiological noxae in Parkinson's disease and related disorders. LC and SN pars compacta neurons both degenerate in Parkinson's disease and other Parkinsonisms; however, LC neurons are comparatively less affected and with a variable degree of involvement. In this study, iron, copper, and their major molecular forms like ferritins, ceruloplasmin, neuromelanin (NM), manganese-superoxide dismutase (SOD), and copper/zinc-SOD were measured in LC and SN of normal subjects at different ages. Iron content in LC was much lower than that in SN, and the ratio heavy-chain ferritin/iron in LC was higher than in the SN. The NM concentration was similar in LC and SN, but the iron content in NM of LC was much lower than SN. In both regions, heavy- and light-chain ferritins were present only in glia and were not detectable in neurons. These data suggest that in LC neurons, the iron mobilization and toxicity is lower than that in SN and is efficiently buffered by NM. The bigger damage occurring in SN could be related to the higher content of iron. Ferritins accomplish the same function of buffering iron in glial cells. Ceruloplasmin levels were similar in LC and SN, but copper was higher in LC. However, the copper content in NM of LC was higher than that of SN, indicating a higher copper mobilization in LC neurons. Manganese-SOD and copper/zinc-SOD had similar age trend in LC and SN. These results may explain at least one of the reasons underlying lower vulnerability of LC compared to SN in Parkinsonian syndromes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Locus coeruleus neurons contain norepinephrine-derived neuromelanin (227, 228); the dorsal motor nucleus of vagus contains neuromelanin that may be dopaminergic (202); and the raphe nuclei contain neuromelanin derived from their neurotransmitter, serotonin.”
From Chemiexcitation: Mammalian Photochemistry in the Dark† (2023) · cites this paper as [228]
In the citing paper
“In healthy ageing, selective accumulation of iron occurs in several brain regions and cell types, with iron mainly bound within ferritin and neuromelanin (panel).5,6”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [6]
In the citing paper
“Neuromelanin is present in neurons as neuromelanin-iron complexes in which the iron content varies depending on the neurons in each brain area.6,53”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [6]
In the citing paper
“Regional distribution of total iron in a healthy adult brain is heterogeneous; the highest iron concentrations were detected in the basal ganglia (putamen, globus pallidus, and caudate nucleus), whereas low concentrations were detected in the cortical grey matter, white matter, midbrain, and cerebellum, and the lowest iron concentrations were in the pons, locus coeruleus, and medulla.6,43,45–47”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [6]
In the citing paper
“In the substantia nigra, ferritin heavy chain and ferritin light chain concentrations increase with age, whereas these are constant in the locus coeruleus; therefore iron could contribute to neurodegeneration in the substantia nigra more than in the locus coeruleus.5,6”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [6]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains
Riederer, P., Sofic, E., Rausch, W., Schmidt, B., Reynolds, G. P., Jellinger, K., & Youdim, M. B. H. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09150.x · Cited by 1,383
Iron accumulation in Alzheimer disease is a source of redox-generated free radicals
Smith, M. A., Harris, P. L. R., Sayre, L. M., & Perry, G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9866 · Cited by 1,355
Dexter, D. T., Wells, F. R., Lee, A. J., Agid, F., Agid, Y., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07264.x · Cited by 1,149
Zarow, C., Lyness, S. A., Mortimer, J. A., & Chui, H. C. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.337 · Cited by 1,002
Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain
Sofic, E., Riederer, P., Heinsen, H., Beckmann, H., Reynolds, G. P., Hebenstreit, G., & Youdim, M. B. H. (1988) · Journal of Neural Transmission · doi:10.1007/bf01244786 · Cited by 752
Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo
Kaur, D., Yantiri, F., Rajagopalan, S., Kumar, J., Mo, J. Q., Boonplueang, R., Viswanath, V., Jacobs, R., Yang, L., Beal, M. F., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00126-0 · Cited by 620
The Neuropathologic Basis of Different Clinical Subgroups of Parkinson's Disease
Paulus, W., & Jellinger, K. (1991) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199111000-00006 · Cited by 554
Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome
Connor, J. R., Boyer, P. J., Menzies, S. L., Dellinger, B., Allen, R. P., Ondo, W. G., & Earley, C. J. (2003) · Neurology · doi:10.1212/01.wnl.0000078887.16593.12 · Cited by 548
Curtis, A. R. J., Fey, C., Morris, C. M., Bindoff, L. A., Ince, P. G., Chinnery, P. F., Coulthard, A., Jackson, M. J., Jackson, A. P., McHale, D. P., et al. (2001) · Nature Genetics · doi:10.1038/ng571 · Cited by 537
Disease‐specific patterns of locus coeruleus cell loss
German, D. C., Manaye, K. F., White, C. L., Woodward, D. J., McIntire, D. D., Smith, W. K., Kalaria, R. N., & Mann, D. M. A. (1992) · Annals of Neurology · doi:10.1002/ana.410320510 · Cited by 512
Research works printed but not linked: 5
- Arnsten, A. F. & Goldman-Rakic, P. S. (1987) J. Neural Transm. 24, 317-324.
- 10.1002/1531-8249(199910)46:4<598::aid-ana7>3.0.co;2-f · DOI
- Wilms, H., Rosenstiel, P., Sievers, J., Deuschl, G., Zecca, L. & Lucius, R. (2003) FASEB J. 17, 500-502.12631585
- Blain, I., Slama, P., Giorgi, M., Tron, T. & Reglier, M. (2002) J. Biotechnol. 90, 95-112.12069196
- Marttila, R. J., Viljanen, M., Toivonen, E., Lorentz, H. & Rinne, U. K. (1990) Adv. Neurol. 53, 141-144.2239455
Cited by
Items 301–400 of 533
Cell-specific copper dyshomeostasis mechanism in Alzheimer’s disease
Okafor, M., Faller, P., & Vitale, N. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00504-6 · Cited by 18
Pesch, B., Dydak, U., Lotz, A., Casjens, S., Quetscher, C., Lehnert, M., Abramowski, J., Stewig, C., Yeh, C., Weiß, T., et al. (2017) · NeuroToxicology · doi:10.1016/j.neuro.2017.08.008 · Cited by 18
Iron as a trigger of neurodegeneration in Parkinson's disease
Friedman, A., Gałązka-Friedman, J., & Bauminger, E. R. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)83023-5 · Cited by 18
Iron, Oxidative Stress and Health
Udipi, S., Ghugre, P., & Gokhale, C. (2012) · Oxidative Stress - Molecular Mechanisms and Biological Effects · doi:10.5772/34975 · Cited by 17
“The central nervous system contains considerable amounts of iron although the regional distribution of the metal differs, thus conferring varying sensitivity to oxidative stress (Zecca et al., 2004; Hall et al., 2010).”
BackgroundCerebrospinal Fluid Iron‐Ferritin Ratio as a Potential Progression Marker for Parkinson's Disease
Maass, F., Michalke, B., Willkommen, D., Canaslan, S., Schmitz, M., Bähr, M., Zerr, I., & Lingor, P. (2021) · Movement Disorders · doi:10.1002/mds.28790 · Cited by 17
Gromadzka, G., Wilkaniec, A., Tarnacka, B., Hadrian, K., Bendykowska, M., Przybyłkowski, A. M., & Litwin, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147545 · Cited by 17
Impact of Autophagy and Aging on Iron Load and Ferritin in Drosophila Brain
Jacomin, A., Geraki, K., Brooks, J., Tjhin, V. T., Collingwood, J. F., & Nezis, I. P. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00142 · Cited by 17
You, P., Li, X., Wang, Z., Wang, H., Dong, B., & Li, Q. (2021) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2021.654381 · Cited by 17
Nishino, Y., Ando, M., Makino, R., Ueda, K., Okamoto, Y., & Kojima, N. (2010) · Neurotoxicity Research · doi:10.1007/s12640-010-9226-7 · Cited by 17
Alemany, S., Vilor‐Tejedor, N., Bustamante, M., Álvarez-Pedrerol, M., Rivas, I., Forns, J., Querol, X., Pujol, J., & Sunyer, J. (2016) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2016.10.010 · Cited by 17
Walter, U. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.41 · Cited by 17
Chemiexcitation: Mammalian Photochemistry in the Dark†
Brash, D. E., & Goncalves, L. C. P. (2023) · Photochemistry and Photobiology · doi:10.1111/php.13781 · Cited by 16
Liu, X. L., Yang, L., Liu, F. T., Wu, P., Zhang, Y., Zhuang, H., Shi, Y., Wang, J., Geng, D. Y., & Li, Y. X. (2020) · BMC Neurology · doi:10.1186/s12883-020-01828-8 · Cited by 16
ATH434 Rescues Pre-motor Hyposmia in a Mouse Model of Parkinsonism
Beauchamp, L. C., Liu, X. M., Vella, L. J., Adlard, P. A., Bush, A. I., Finkelstein, D. I., & Barnham, K. J. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01300-0 · Cited by 16
Oral curcumin supplementation improves fine motor function in the middle-aged rhesus monkey
Moore, T. L., Bowley, B. G. E., Shultz, P. L., Calderazzo, S. M., Shobin, E., Uprety, A. R., Rosene, D. L., & Moss, M. B. (2018) · Somatosensory & Motor Research · doi:10.1080/08990220.2018.1432481 · Cited by 16
Lower Circulating Lymphocyte Count Predicts ApoE ε4‐Related Cognitive Decline in Parkinson's Disease
Tsukita, K., Sakamaki‐Tsukita, H., & Takahashi, R. (2021) · Movement Disorders · doi:10.1002/mds.28799 · Cited by 16
Oxidative Stress in Parkinson's Disease
Vaya, J., Aluf, Y., & Finberg, J. P. M. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-514-9_12 · Cited by 16
Neuromelanin? MRI of catecholaminergic neurons
Watanabe, T. (2023) · Brain · doi:10.1093/brain/awad393 · Cited by 16
Parkin coregulates glutathione metabolism in adult mammalian brain
Kodsi, D. N. E., Tokarew, J. M., Sengupta, R., Lengacher, N. A., Chatterji, A., Nguyen, A., Boston, H., Jiang, Q., Palmberg, C., Pileggi, C. A., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01488-4 · Cited by 15
Wimalasena, K., Adetuyi, O. A., & Eldani, M. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1339295 · Cited by 15
Selective dopaminergic neurotoxicity modulated by inherent cell-type specific neurobiology
Currim, F., Tanwar, R., Brown-Leung, J. M., Paranjape, N., Liu, J., Sanders, L. H., Doorn, J. A., & Cannon, J. R. (2024) · NeuroToxicology · doi:10.1016/j.neuro.2024.06.016 · Cited by 15
Bagheri, S., Saboury, A. A., Haertlé, T., Rongioletti, M. C. A., & Saso, L. (2022) · Inorganics · doi:10.3390/inorganics10010006 · Cited by 15
Bacchella, C., Dell’Acqua, S., Nicolis, S., Monzani, E., & Casella, L. (2021) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.0c02243 · Cited by 15
Human nigral and liver iron – comparison by Mössbauer spectroscopy, electron microscopy and ELISA
Gałązka-Friedman, J., Bauminger, E. R., Friedman, A., Koziorowski, D., & Szlachta, K. A. (2005) · Hyperfine Interactions · doi:10.1007/s10751-006-9287-4 · Cited by 15
Vano, L. J., McCutcheon, R. A., Sedlacik, J., Kaar, S. J., Rutigliano, G., Nordio, G., Finelli, V., Townsend, L., Berry, A., Statton, B. K., et al. (2025) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20240512 · Cited by 14
Capucciati, A., Monzani, E., Sturini, M., Nicolis, S., Zucca, F. A., Bubacco, L., Bortolus, M., Zecca, L., & Casella, L. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202204787 · Cited by 14
Self-citationChen, H.-Y., Parent, J. H., Ciampa, C. J., Dahl, M. J., Hämmerer, D., Maaß, A., Winer, J. R., Yakupov, R., Inglis, B. A., Betts, M. J., et al. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1236335 · Cited by 14
A reappraisal of Fe(III) adsorption by melanin
Schroeder, R. L., & Gerber, C. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1236-9 · Cited by 14
Neuronal Proteins as Targets of 3-Hydroxykynurenine: Implications in Neurodegenerative Diseases
Capucciati, A., Galliano, M., Bubacco, L., Zecca, L., Casella, L., Monzani, E., & Nicolis, S. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00265 · Cited by 14
Self-citationQuantitative Susceptibility Mapping of the Substantia Nigra in Parkinson’s Disease
Zhao, X., An, H., Liu, T., Shen, N., Bo, B., Zhang, Z., Weng, P., Chen, M., Pei, M., Wang, Y., et al. (2017) · Applied Magnetic Resonance · doi:10.1007/s00723-017-0877-x · Cited by 14
Biesemeier, A., Eibl, O., Eswara, S., Audinot, J., Wirtz, T., & Schraermeyer, U. (2017) · Metallomics · doi:10.1039/c7mt00259a · Cited by 14
Redox System Dysfunction as a Key Mechanism in Autism Spectrum Disorder Pathogenesis
de Oliveira, C. A., Iorio, E. L., & Espíndola, F. S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26209850 · Cited by 13
Okitsu, M., Sugaya, K., Nakata, Y., Kawazoe, T., Ikezawa, J., Okiyama, R., & Takahashi, K. (2023) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2023.120660 · Cited by 13
Porter, J., Arreguin, S., & Pierpont, C. G. (2010) · Inorganica Chimica Acta · doi:10.1016/j.ica.2010.05.011 · Cited by 13
Light pigmentation phenotype is correlated with increased substantia nigra echogenicity
Rumpf, J., Schirmer, M., Fricke, C., Weise, D., Wagner, J. A., Šimon, J., & Claßen, J. (2015) · Movement Disorders · doi:10.1002/mds.26427 · Cited by 13
The effect of neuromelanin on the proteasome activity in human dopaminergic SH-SY5Y cells
Maruyama, W., Shamoto‐Nagai, M., Akao, Y., Riederer, P. F., & Naoi, M. (2006) · Springer eBooks · doi:10.1007/978-3-211-45295-0_20 · Cited by 13
In silico evidence for glutathione- and iron-related pathogeneses in Parkinson's disease
Yeager, M. P., & Coleman, R. A. (2010) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2010.01.034 · Cited by 12
Carving the senescent phenotype by the chemical reactivity of catecholamines: An integrative review
Golubev, A. G. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101570 · Cited by 12
Detection of molecular markers of ferroptosis in human Alzheimer's disease brains
Mayr, E., Rotter, J., Kuhrt, H., Winter, K., Stassart, R. M., Streit, W. J., & Bechmann, I. (2024) · Journal of Alzheimer s Disease · doi:10.1177/13872877241296563 · Cited by 11
Fundamental mechanism of ferroptosis: Three unanswered questions
Feinsod, H., & Stockwell, B. R. (2025) · Ferroptosis and Oxidative Stress · doi:10.70401/fos.2026.0015 · Cited by 11
Fang, K., Han, S., Li, Y., Ding, J., Wu, J., & Zhang, W. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.733316 · Cited by 12
An XAS study of the sulfur environment in human neuromelanin and its synthetic analogs
Crippa, P. R., Eisner, M., Morante, S., Stellato, F., Vicentin, F. C., & Zecca, L. (2009) · European Biophysics Journal · doi:10.1007/s00249-009-0462-9 · Cited by 11
Self-citationIron as a risk factor in neurological diseases
Gałązka-Friedman, J. (2008) · Hyperfine Interactions · doi:10.1007/s10751-008-9723-8 · Cited by 11
Saturation Binding of Nicotine to Synthetic Neuromelanin Demonstrated by Fluorescence Spectroscopy
Haining, R. L., Jones, T. M., & Hernandez, A. (2016) · Neurochemical Research · doi:10.1007/s11064-016-2068-9 · Cited by 11
Bae, Y. J., Song, Y. S., Kim, J., Choi, B. S., Nam, Y., Choi, J.-H., Lee, W. W., & Kim, J. H. (2021) · American Journal of Neuroradiology · doi:10.3174/ajnr.a6960 · Cited by 11
Mechanism of DNA Damage and Apoptosis Induced by Tetrahydropapaveroline, a Metabolite of Dopamine
Kobayashi, H., Oikawa, S., & Kawanishi, S. (2006) · Neurochemical Research · doi:10.1007/s11064-006-9044-8 · Cited by 11
Sandwich spatial saturation for neuromelanin-sensitive MRI: Development and multi-center trial
Ji, S., Choi, E., Sohn, B., Baik, K., Shin, N., Moon, W., Park, S., Song, S., Lee, P. H., Shin, D. H., et al. (2022) · NeuroImage · doi:10.1016/j.neuroimage.2022.119706 · Cited by 10
Khan, M. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115283 · Cited by 10
Fornstedt, B. (2024) · Journal of Neural Transmission · doi:10.1007/s00702-023-02718-2 · Cited by 10
HFE Mutations in Neurodegenerative Disease as a Model of Hormesis
Marshall, S., & Connor, J. R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063334 · Cited by 10
Schifano, F., Magnaghi, L. R., Monzani, E., Casella, L., & Biesuz, R. (2024) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2024.112548 · Cited by 10
Iron treatment inhibits Aβ42 deposition in vivo and reduces Aβ42/Aβ40 ratio
Shen, X., Liu, J., Fujita, Y., Liu, S., Maeda, T., Kikuchi, K., Obara, T., Takebe, A., Sayama, R., Takahashi, T., et al. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.01.119 · Cited by 10
The Proteome of Neuromelanin Granules in Dementia with Lewy Bodies
Wulf, M., Barkovits, K., Schork, K., Eisenacher, M., Riederer, P. F., Gerlach, M., Eggers, B., & Marcus, K. (2022) · Cells · doi:10.3390/cells11223538 · Cited by 10
Hussei, S. A., Az, M. E.-S., & El-S, S. K. (2013) · Asian Journal of Clinical Nutrition · doi:10.3923/ajcn.2014.1.17 · Cited by 10
Polysaccharide-Mediated Synthesis of Melanins from Serotonin and Other 5-Hydroxy Indoles
Vercruysse, K. P., Clark, A. M., Alatas, N., Brooks, D., Hamza, N., & Whalen, M. M. (2018) · Future Science OA · doi:10.4155/fsoa-2017-0118 · Cited by 10
Kwon, K., Cho, H., Lee, S.-Y., Cho, E. J., Yu, W., Kok, C. Y. L., Je, H. S., Kim, J., Cho, H. J., & Kwon, T. (2022) · Aging Cell · doi:10.1111/acel.13694 · Cited by 9
Monzani, E., Nicolis, S., Dell’Acqua, S., Capucciati, A., Bacchella, C., Zucca, F. A., Mosharov, E. V., Sulzer, D., Zecca, L., & Casella, L. (2019) · Angewandte Chemie · doi:10.1002/ange.201811122 · Cited by 9
Self-citationCastiglioni, E., Finazzi, D., Goldwurm, S., Pezzoli, G., Forni, G., Girelli, D., Maccarinelli, F., Poli, M., Ferrari, M., Cremonesi, L., et al. (2010) · Parkinson s Disease · doi:10.4061/2011/827693 · Cited by 9
Self-citationBush, W. D., Garguilo, J., Zucca, F. A., Bellei, C., Nemanich, R. J., Edwards, G. S., Zecca, L., & Simon, J. D. (2008) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2008.00476.x · Cited by 9
Self-citationRashid, T., Hwang, R. S., DiMarzio, M. D., Hancu, I., & Pilitsis, J. G. (2019) · Journal of Neuroradiology · doi:10.1016/j.neurad.2019.04.007 · Cited by 9
Dahl, M. J., Mather, M., Düzel, S., Bodammer, N. C., Lindenberger, U., Kühn, S., & Werkle‐Bergner, M. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/332098 · Cited by 9
Sources of Oxidative Stress in Parkinson’s Disease: Pathways and Therapeutic Implications
Yordanov, Y., Stefanova, D., Kondeva-Burdina, M., & Tzankova, V. (2026) · Antioxidants · doi:10.3390/antiox15020187 · Cited by 8
Mitochondrial dysfunction, iron accumulation, and ferroptosis in Parkinson’s disease
Teferi, N., Challa, M., Woodiwiss, T. R., Allen, B. G., & Petronek, M. S. (2023) · Redox Experimental Medicine · doi:10.1530/rem-23-0004 · Cited by 8
Mitra, R. S., Premraj, L., & Khoo, T. K. (2023) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2023.105448 · Cited by 8
Hussain, S., Menchaca, I., Shalchy, M. A., Yaghoubi, K. C., Langley, J. A., Seitz, A. R., Hu, X. P., & Peters, M. A. K. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.110733 · Cited by 8
Norepinephrine–Fe(III)–ATP Ternary Complex and Its Relevance to Parkinson’s Disease
Kou, L., Duan, Y., Wang, P., Fu, Y., Darabedian, N., He, Y., Jiang, D., Chen, D., Xiang, J., Liu, G., et al. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00009 · Cited by 8
Iron level changes in the brain with neurodegenerative disease
Bazala, R., Zoppellaro, G., & Kletetschka, G. (2023) · Brain Multiphysics · doi:10.1016/j.brain.2023.100063 · Cited by 8
Vermilyea, S., Guthrie, S., Hernandez, I., Bondarenko, V., & Emborg, M. E. (2019) · Cell Transplantation · doi:10.1177/0963689719835794 · Cited by 8
Wallstein, N., Capucciati, A., Pöppl, A., Schnohr, C. S., Sturini, M., Pampel, A., Jäger, C., Zecca, L., Zucca, F. A., Monzani, E., et al. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202509102 · Cited by 7
Self-citationJiménez-Jiménez, F. J., Alonso‐Navarro, H., García‐Martín, E., Martín-Gómez, M. Á., Salgado-Cámara, P., Cárcamo-Fonfría, A., Arroyo-Solera, M., & Agúndez, J. A. G. (2026) · Cells · doi:10.3390/cells15030288 · Cited by 7
Chen, H., Xu, J., Li, W., Hu, Z., Ke, Z., Qin, R., & Xu, Y. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02861-8 · Cited by 7
Fading Blue: Exploring the Causes of Locus Coeruleus Damage Across the Lifespan
Galgani, A., Scotto, M., Faraguna, U., & Giorgi, F. S. (2025) · Antioxidants · doi:10.3390/antiox14030255 · Cited by 7
Gradients of Nigrostriatal Iron Deposition in Healthy Aging and Synucleinopathies
Wen, J., Guo, T., Duanmu, X., Wu, C., Wu, H., Zhou, C., Zheng, Q., Yuan, W., Qin, J., Zhu, Z., et al. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70359 · Cited by 7
Suryana, E., Rowlands, B. D., Bishop, D., Finkelstein, D. I., & Double, K. L. (2024) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2024.01.003 · Cited by 7
Iron-induced Damage in Corpus Striatal Cells of Neonatal Rats: Attenuation by Folic Acid
Eldien, H. M. S., Mohamed, A., & Hussein, M. R. (2012) · Ultrastructural Pathology · doi:10.3109/01913123.2011.630125 · Cited by 7
Fink, J., Pathak, H., Smith, J. M., Achat‐Mendes, C., & Haining, R. L. (2019) · Biomolecules · doi:10.3390/biom9050175 · Cited by 7
Yu, J., Ding, Y., Wu, D., & Liu, P. (2023) · Biological Trace Element Research · doi:10.1007/s12011-023-03682-4 · Cited by 7
Noradrenergic–Dopaminergic Interactions Due to DSP-4–MPTP Neurotoxin Treatments: Iron Connection
Archer, T. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_411 · Cited by 7
Xu, R., Soavi, F., & Santato, C. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00227 · Cited by 7
Kodsi, D. N. E., Tokarew, J. M., Sengupta, R., Lengacher, N. A., Ng, A. C., Boston, H., Jiang, Q., Palmberg, C., Pileggi, C. A., Shutinoski, B., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.26.062380 · Cited by 7
Self-citationLiu, X., Wang, N., Xie, M., Yang, L., Wu, P., Liu, F., & Li, Y. (2025) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.70110 · Cited by 5
Ahmad, A., Rabbani, G., Mohammad, A., Zamzami, M. A., Hosawi, S. B. I., Baothman, O. A. S., Choudhary, H., Zeyadi, M., Ahmad, V., & Lee, J. (2025) · Microchemical Journal · doi:10.1016/j.microc.2025.115677 · Cited by 5
Liu, L., Wang, T., Zhou, H., Zheng, J., Liu, Q., Wang, W., Liu, X., Zhang, X., Ge, D., Shi, W., et al. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202402718 · Cited by 5
Gałązka-Friedman, J., Bauminger, E. R., & Friedman, A. (2013) · Wiley eBooks · doi:10.1002/9781118714614.ch16 · Cited by 5
Movement disorders: Neurodevelopment and neurobehavioural expression
Archer, T., & Beninger, R. J. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0572-9 · Cited by 5
Yorbık, Ö., Mutlu, C., Ozdag, M. F., Olgun, A., Eryılmaz, G., & Ayta, S. (2016) · Nöro Psikiyatri Arşivi · doi:10.5152/npa.2016.12659 · Cited by 5
Quick MR Neuromelanin Imaging Using a Chemical Shift Selective Pulse
Kusama, M., Sato, N., Kimura, Y., & Miyagi, K. (2020) · Magnetic Resonance in Medical Sciences · doi:10.2463/mrms.tn.2019-0167 · Cited by 5
Risk of Migraine in Europeans with Low Melanin Levels—A Population Based Case-Control Study
Kobus, M., Żądzińska, E., Sitek, A., Pełka, J., Rózniecki, J., & Antoszewski, B. (2022) · Brain Sciences · doi:10.3390/brainsci12050620 · Cited by 5
Николаевич, С. В., & Худоерков, Р. М. (2019) · Advances in Gerontology · doi:10.1134/s207905701902019x · Cited by 5
Modifiers of Protein Aggregation—From Nonspecific to Specific Interactions
Levy‐Sakin, M., Scherzer‐Attali, R., & Gazit, E. (2012) · Wiley eBooks · doi:10.1002/9781118183373.ch15 · Cited by 5
Targeting dysregulation of brain iron homeostasis in ageing
Weinreb, O., Amit, T., & Youdim, M. B. H. (2012) · Nutrition and Aging · doi:10.3233/nua-2012-0003 · Cited by 5
Dahl, M. J., Mather, M., Düzel, S., Bodammer, N., Lindenberger, U., Kühn, S., & Werkle‐Bergner, M. (2019) · MPG.PuRe (Max Planck Society) · Cited by 5
Murphy, E. K., Perl, D. P., Day, R. M., & Iacono, D. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01136-3 · Cited by 4
Bae, J., Gong, Z., Mazucanti, C. H., Bilgel, M., Laporte, J. P., Faulkner, M. E., Guo, A., Bergeron, C. M., Egan, J. M., Resnick, S. M., et al. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01809-4 · Cited by 4
Tyrosine Hydroxylase-Immunopositive Cells and Melanin in the Mesencephalon of Yugan Black-Bone Fowl
Chu, M., Liu, Y., Si, Y., Yu, H., Ye, Y., Zhao, H., & Zhang, H. (2021) · Journal of Microscopy and Ultrastructure · doi:10.4103/jmau.jmau_50_20 · Cited by 4
Advances in magnetic resonance imaging
Wilson, H., de Natale, E. R., & Politis, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821651-4.00009-9 · Cited by 4
Changes in iron content in brain structures during aging and associated neurodegenerative diseases
Николаевич, С. В., & Khudoyerkov, R. M. (2020) · Russian Journal of Archive of Pathology · doi:10.17116/patol20208205173 · Cited by 4
Single-Cell Approaches for Studying the Role of Mitochondrial DNA in Neurodegenerative Disease
Bailey, L. J., Elson, J. L., & Pienaar, I. S. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1270-5_19 · Cited by 4
Modulation of Iron Catalytic Activity to Dopamine Oxidation through Additional Iron Ligation
La, M., Chen, C.-D., Li, H., & Yang, C. (2014) · International Journal of Electrochemical Science · doi:10.1016/s1452-3981(23)10937-0 · Cited by 4
Use of Mri to Monitor Parkinson’s Disease
Planetta, P. J., Prodoehl, J., Corcos, D. M., & Vaillancourt, D. E. (2011) · Neurodegenerative Disease Management · doi:10.2217/nmt.10.6 · Cited by 4
Metadata
- Authors
- Zecca, L., Stroppolo, A., Gatti, A., Tampellini, D., Toscani, M., Gallorini, M., Giaveri, G., Arosio, P., Santambrogio, P., Fariello, R. G., Karatekin, E., Kleinman, M. H., Turro, N., Hornykiewicz, O., & Zucca, F. A.
- Affiliations
- Institute of Biomedical Technologies (IT)
- University of Vienna (AT)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2004-06-21
- Volume
- 101
- Issue
- 26
- Pages
- 9843-9848
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC470762
- OpenAlex
- W2116294955
- Cited by
- 495
- References
- 51
- Citations by year
- 2026: 14 · 2025: 28 · 2024: 31 · 2023: 30 · 2022: 37 · 2021: 46 · 2020: 31 · 2019: 41 · 2018: 23 · 2017: 18 · 2016: 21 · 2015: 22 · 2014: 18 · 2013: 14 · 2012: 21
- FWCI
- 7.38
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Keywords
- iron, copper, locus coeruleus, substantia nigra, Parkinson's disease, neuronal vulnerability, aging, neuromelanin, ferritin, ceruloplasmin, manganese superoxide dismutase, copper-zinc superoxide dismutase, iron mobilization, iron toxicity, brainstem
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Aging, Ceruloplasmin, Copper, Electron Spin Resonance Spectroscopy, Female, Ferritins, Homeostasis, Humans, Iron, Iron Chelating Agents, Locus Coeruleus, Male, Melanins, Middle Aged, Neuroglia, Neurons, Substantia Nigra, Superoxide Dismutase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.